[Antiandrogen strategies in prostate cancer: reconstitution of oestrogen receptor beta]
- PMID: 20725712
- DOI: 10.1007/s00120-010-2370-0
[Antiandrogen strategies in prostate cancer: reconstitution of oestrogen receptor beta]
Abstract
In advanced prostate cancer, albeit castration resistant, an active androgen receptor is still pivotal for growth and cell survival. Recent therapies involving more effective antiandrogens such as MDV3100 proved to be successful. Furthermore, blocking de novo intracrine androgen synthesis, e.g. with abiraterone acetate, provides additional benefit. Besides these antiandrogen measures, compounds which enable the reconstitution of the oestrogen receptor beta as a tumour suppressor restrain aberrant androgen receptor signalling.
Similar articles
-
A novel antiandrogen, Compound 30, suppresses castration-resistant and MDV3100-resistant prostate cancer growth in vitro and in vivo.Mol Cancer Ther. 2013 May;12(5):567-76. doi: 10.1158/1535-7163.MCT-12-0798. Epub 2013 Mar 14. Mol Cancer Ther. 2013. PMID: 23493310
-
Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.Adv Cancer Res. 2015;127:123-58. doi: 10.1016/bs.acr.2015.03.001. Epub 2015 Mar 29. Adv Cancer Res. 2015. PMID: 26093899 Review.
-
Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells.J Urol. 2016 May;195(5):1588-1597. doi: 10.1016/j.juro.2015.11.071. Epub 2015 Dec 9. J Urol. 2016. PMID: 26682754
-
Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer.Annu Rev Med. 2013;64:1-13. doi: 10.1146/annurev-med-121211-091605. Epub 2012 Sep 27. Annu Rev Med. 2013. PMID: 23020876 Review.
-
Investigational therapies targeting the androgen signaling axis and the androgen receptor and in prostate cancer - recent developments and future directions.Expert Opin Investig Drugs. 2018 Oct;27(10):811-822. doi: 10.1080/13543784.2018.1513490. Epub 2018 Aug 31. Expert Opin Investig Drugs. 2018. PMID: 30118330 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical